Close this search box.

Large-Cap Pharmaceutical Stocks

U.S. Exchanges

List of Publicly Traded Large-Cap Pharmaceutical Companies Listed on Major U.S. Exchanges

This list includes large-sized pharmaceutical companies with market capitalizations of over ten billion dollars. We update this page at the start of every month, so it is possible that during the course of a month a company’s market cap might fall below ten billion. Additional pharmaceutical companies can be found in the following sections:

List of Pharmaceutical Companies

Mid-Cap Pharmaceuticals

Small-Cap Pharmaceuticals

Micro-Cap Pharmaceuticals

Biopharmaceutical companies are generally not included in this list of companies and can be found in our Biotech section. In parentheses, you will find a short description or areas of focus for the company.

A comparison widget that shows trend, earnings per share (EPS), P/E ratio, and beta for each of the companies on this list can be accessed through the link below.

Large-Cap Pharmaceutical Industry Comparison Widget

Select the company’s link to access charts, news links, and company website and social media information.

Pharmaceuticals: Large-Cap Stocks

Abbott Laboratories (ABT) (Nutritional products; medical devices, diagnostics, branded generic pharmaceuticals: gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products, respiratory drugs, and vaccines, vascular products)

Allergan, Inc. (AGN) (Branded pharmaceuticals: dermatology and aesthetics, central nervous system, eye care, women’s health and urology, gastroenterology, anti-infectives)

AmerisourceBergen Corporation (ABC) (Pharmaceutical sourcing and distribution)

Cardinal Health, Inc. (CAH) (Drug and healthcare product distribution, consumer healthcare products, direct-to-home medical supplies distributor)

Eli Lilly and Company (LLY) (Animal health, cardiovascular, critical care, diabetes, men’s health, musculoskeletal, neuroscience, oncology)

GlaxoSmithKline Plc. (GSK) (United Kingdom: prescription medicines, vaccines, and consumer healthcare products)

Johnson & Johnson (JNJ) (Consumer health products: baby care, skin care, oral care, wound care, and women’s health care; Medical devices: diabetes care, diagnostics, orthopedics, neurological disease, vision care, infection prevention, cardiovascular disease, and aesthetics; Pharmaceutical: cardiovascular and metabolic diseases, immunology, infectious diseases, neuroscience, oncology)

McKesson Corporation (MCK) (Pharmaceutical distributor; software; automation technology; business services and consulting; Health Mart retail pharmacy franchises)

Merck & Company, Inc. (MRK) (Pharmaceuticals: cardiovascular, diabetes, general medicine, immunology, infectious diseases, oncology, respiratory, women’s health; Vaccines, Animal Health Products)

Mylan Inc. (MYL) (Generic, branded generic, and specialty pharmaceuticals)

Novartis AG (NVS) (Switzerland: eye care, generic pharmaceuticals, medicines)

Novo Nordisk (NVO) (Denmark: diabetes and other serious chronic conditions)

Perrigo Company (PRGO) (Ireland: generic over-the-counter, prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients)

Pfizer, Inc. (PFE) (Consumer healthcare products; vaccines; oncology; examples of medicines include treatments for the following areas: cardiovascular/metabolic, inflammation, neuroscience, pain, rare diseases, women’s/men’s health)

Sanofi (SNY) (France: animal health products, consumer healthcare products, generic drugs, vaccines; drugs for diabetes, rare diseases, multiple sclerosis, and oncology)

Teva Pharmaceutical Industries Limited (TEVA) (Israel: generic drugs, specialty pharmaceuticals, active pharmaceutical ingredients)

Zoetis Inc. (ZTS) (Animal health medicines and vaccines, diagnostic products, and genetic tests)

Related Links:

Publicly Traded Companies by Sector and Industry

List of Pharmaceutical Companies

List of Pharmaceutical ETFs

List of Biotech Companies

List of Healthcare Companies

List of Large-Cap Stocks